Vimarsana
Biggest News Aggregation in the World

Italian Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Italian Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Italian Network Today - Breaking & Trending Today

Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - Vimarsana News

Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

RAPIDe-3, a global pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, is currently enrollingEnd-of-Phase 2 meeting...

Italy sent Israel arms during Gaza war contrary to denials - Vimarsana News

Italy sent Israel arms during Gaza war contrary to denials

Despite Italy's denials, arms sales to Israel went on during the war. Altreconomia magazine reveals exports worth $890,000 in October and November.

Third World March: starting with European coordination - Vimarsana News

Third World March: starting with European coordination

On October 2nd there was the presentation of the World March for Peace and Nonviolence third edition, at the Congress of Deputies of Spain in connection

Intesa Sanpaolo S p A : City Green Light receives 197 million for sustainable projects with italian municipalities -September 22, 2023 at 05:50 am EDT - Vimarsana News

Intesa Sanpaolo S p A : City Green Light receives 197 million for sustainable projects with italian municipalities -September 22, 2023 at 05:50 am EDT

PRESS RELEASE CITY GREEN LIGHT RECEIVES 197 MILLION FOR SUSTAINABLE PROJECTS WITH ITALIAN MUNICIPALITIES The resources...

Selective publication of antidepressant trials and its influence on apparent efficacy: Updated comparisons and meta-analyses of newer versus older trials - Vimarsana News

Selective publication of antidepressant trials and its influence on apparent efficacy: Updated comparisons and meta-analyses of newer versus older trials

Author summary Why was this study done? ➢ Clinicians and researchers depend on the peer-reviewed literature for accurate assessments of drug efficacy and safety, but this depends on whether the outcomes of all trials—negative, as well as positive—are reported transparently. ➢ In an earlier study, using Food and Drug Administration (FDA) review documents as a gold standard, we found that many negative trials had been misreported in the published literature as having positive outcomes or had simply not been published. ➢ Since then, reporting bias has been the s...

Source: plos.org